$30M trans-Tasman medical research fund
A new trans-Tasman $30.0-million research commercialization fund for local universities - announced at the BIO 2008 conference in San Diego, USA, by the Prime Minister of Australia's Victoria state, John Brumby, and in New Zealand by that country's Minister for Economic Development Pete Hodgson - will drive research into life-saving medical technology.
Mr Brumby said the Victorian government was contributing $1.25 million towards the fund, along with the governments of New Zealand and South Australia, to capture some of the best ideas from researchers and develop them into new businesses and products. "This new $30.0 million fund will help drive new breakthroughs in a range of medical research areas to save lives," he added.
Includes Ab research for cancer, etc
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze